| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
07-24-2015, 11:34 PM
|
#1 | ||
|
|||
|
Senior Member
|
Until now [1]:
"Duodopa has only been available on the NHS in England ... through an individual funding request (IFR) for each patient, which critics said often created a time-consuming administrative burden and led to postcode lotteries in access to the treatment." On 2nd July it was decided to [2]: "The following treatments and services will be routinely commissioned: •Duodopa as a treatment to control the symptoms of patients with advanced Parkinson’s Disease ... " References [1] http://www.pharmafile.com/news/49746...nson-s-disease [2] http://www.england.nhs.uk/2015/07/02...ent-decisions/ John
__________________
Born 1955. Diagnosed PD 2005. Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg |
||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Anyone know how Duodopa is going? | Parkinson's Disease Clinical Trials | |||
| this could be duodopa | Parkinson's Disease | |||
| Can anyone please update us about duodopa? | Parkinson's Disease Clinical Trials | |||
| Duodopa | Parkinson's Disease | |||
NHS (England) to fund Duodopa treatments
Linear Mode
